Pasadena, California-based Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust that pioneered the life science real estate niche, focusing on the ownership, operation, and development of collaborative “Megacampus” ecosystems. Valued at a\u00a0market cap of $7.5 billion, the company\u00a0is scheduled to announce its fiscal\u00a0Q1 earnings for 2026 after the market closes on Monday, Apr. 27.<\/p>\n
Ahead of this event, analysts expect this\u00a0life science REIT\u00a0to report a\u00a0profit of $1.74 per share, down 24.4% from\u00a0$2.30 per share in the year-ago quarter.\u00a0The company has topped Wall Street\u2019s earnings estimates in three of the last four quarters, while missing on another occasion. In Q4 2025, ARE\u2019s EPS of $2.16 outpaced the consensus estimates by a penny.<\/p>\n
For the current fiscal year, ending in December, analysts expect ARE to report a profit of $6.41 per share, representing a 28.9% decrease from\u00a0$9.01 per share in fiscal 2025. Its EPS is expected to further decline 5.9% year-over-year to $6.03 in fiscal 2027.<\/p>\n ARE has\u00a0declined 55% over the past 52 weeks, significantly trailing both the S&P 500 Index’s ($SPX)\u00a016.7% return and the State Street Real Estate Select Sector SPDR ETF\u2019s (XLRE)\u00a03% drop over the same time period.<\/p>\n On Feb. 10, ARE\u00a0shares climbed 1.2% after the\u00a0company priced a $750 million public offering of 5.25% senior notes due 2036. The notes were issued at a modest discount, implying a yield of 5.291%, and are unsecured, with support from its subsidiary. The company intends to use the proceeds largely to refinance existing debt linked to a prior tender offer, with any interim funds directed toward short-term investments or general corporate needs.<\/p>\n Wall Street analysts are\u00a0cautious about ARE\u2019s stock, with a “Hold” rating overall. Among 17 analysts covering the stock, three recommend “Strong Buy,” 13 advise “Hold,\u201d and one suggests a “Strong Sell” rating. The mean price target for ARE is $58.71, indicating a 38.5% potential upside from the current levels.<\/p>\n On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally\u00a0published on Barchart.com <\/i><\/p>\n<\/p><\/div>\n<\/div>\n<\/div>
<\/div>\n<\/div>